<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Masiero, Giuliano</dc:creator>
  <dc:creator>Filippini, Massimo</dc:creator>
  <dc:creator>Ferech, Matus</dc:creator>
  <dc:creator>Goossens, Herman</dc:creator>
  <dc:date>2010</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Objectives: Outpatient antibiotic consumption widely varies across Europe. The  investigation of the causes of such variation may help to identify interventions that  would improve the efficient use of antibiotics. The aim of this study was to assess  the impact of socioeconomic determinants and the role played by information about  bacterial resistance. Methods: Comparable data on systemically administered  antibiotics and socioeconomic determinants in 17 European countries were  available between 200 and 2005. We estimated an ad hoc econometric model by  means of a hybrid log–log functional form and random effects generalised least  squares regressions. Lagged values and the instrumental variable method were  applied to address endogeneity of bacterial resistance and infections. Bacterial  resistance was measured by the rate of penicillin non-susceptible Streptococcus  pneumoniae isolates (PNSP) and methicillin-resistant Staphylococcus aureus  (MRSA). Results: The population income, demographic structure, density of general  practitioners and their remuneration method appeared to be significant determinants  of antibiotic consumption. Although countries with higher levels of bacterial  resistance exhibited significantly higher levels of per capita antibiotic use, ceteris  paribus, the responsiveness of antibiotic use to changes in bacterial resistance  was relatively low (0.09–0.18). Conclusions: The study confirms that  socioeconomic factors should be taken into account while explaining differences in  outpatient antibiotic use across countries. The impact of supply-side factors and  incentives attached to payment schemes for physicians need to be considered in  government interventions to reduce inequalities and improve effectiveness in  antibiotic utilisation.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://n2t.net/ark:/12658/srd1318198</dc:identifier>
  <dc:identifier>https://susi.usi.ch/global/documents/318198</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/318198/files/masiero_ijph_2010.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1007/s00038-010-0167-y</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1318198</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>International Journal of Public Health. - 2010, vol. 55, no. 5, p. 469–478</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Antibiotic use</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Cross-country variations</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Bacterial resistance</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Socioeconomic inequalities</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/33</dc:subject>
  <dc:title xmlns:ns5="xml" ns5:lang="en">Socioeconomic determinants of outpatient antibiotic use in Europe</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
